Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial

Alparslan Turan(Cleveland Clinic), Syed Atif Raza, Paul C. Fitzgerald(Northwestern University), Praneeta Chodavarapu, Sergio D. Bergese(Neurological Surgery), Kurt Ruetzler(Cleveland Clinic), Carlos Trombetta(Cleveland Clinic), Chetan Lokhande, Daniel I. Sessler(Outcomes Research Consortium), Jennifer Hargrave(Cleveland Clinic), Zohaib Akhtar, Gildasio De Oliveira, Kimberly Howard‐Quijano(University of Pittsburgh Medical Center), Guangmei Mao(Cleveland Clinic), Gausan Ratna Bajracharya, Jonathan Fang(Outcomes Research Consortium), Evis Cuko, Matthew T. Hutcherson, Andra E. Duncan(Cleveland Clinic), Andrew J. Feider(University of Iowa Hospitals and Clinics), Hassan Hamadnalla(Cleveland Clinic), Dilara Khoshknabi, Quinton Riter, Nika Karimi(University of Rochester), Hooman Honar, Manal Salah Hassan(Cleveland Clinic), Azfar Niazi, Mohammad Zafeer Khan, Logan Glosse, Kavita Elliott, Marc Gillinov(Cleveland Clinic), Steve Leung(MetroHealth), Sabry Ayad(Cleveland Clinic), Partha Saha, Seyhan Yağar
The Lancet
July 1, 2020
Cited by 303


Related Papers